Guaynabo, Puerto Rico Clinical Trials

A listing of Guaynabo, Puerto Rico clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
dulaglutide
tirzepatide
cardiovascular disease
Advanced Clinical Research, LLC
 (5.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

ly573144
preventive medication
treatment regimen
headache
migraine
Headache Center of Puerto Rico
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy

Endocrine therapy is the initial treatment for most hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancers. This study will evaluate the use of venetoclax in combination with capecitabine in adult participants with HR+, HER2-, metastatic breast cancer (MBC) who had disease progression following treatment …

primary tumor
capecitabine tablets
erbb2
HER2
metastatic breast cancer
GCM Medical Group PSC - Hato Rey /ID# 216904
 (5.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +15 other locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

carcinoma
refractory multiple myeloma
isatuximab
line of therapy
multiple myeloma
Investigational Site Number 8400001
 (5.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

HIV Infection
antibody test
covid-19
targeted therapy
radiation therapy, targeted
Centro Comprensivo de Cancer de UPR
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +575 other locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

therapy
isatuximab
multiple myeloma
cancer
complete resection
Investigational Site Number 8400001
 (5.8 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +9 other locations